CN107184963A - 一种医用敷料的制备方法 - Google Patents

一种医用敷料的制备方法 Download PDF

Info

Publication number
CN107184963A
CN107184963A CN201710501553.9A CN201710501553A CN107184963A CN 107184963 A CN107184963 A CN 107184963A CN 201710501553 A CN201710501553 A CN 201710501553A CN 107184963 A CN107184963 A CN 107184963A
Authority
CN
China
Prior art keywords
sodium hyaluronate
medical dressing
parts
preparation
mixed solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201710501553.9A
Other languages
English (en)
Inventor
马英祥
姜晓筑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Jiabaoxiang Biological Technology Co Ltd
Original Assignee
Chengdu Jiabaoxiang Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Jiabaoxiang Biological Technology Co Ltd filed Critical Chengdu Jiabaoxiang Biological Technology Co Ltd
Priority to CN201710501553.9A priority Critical patent/CN107184963A/zh
Publication of CN107184963A publication Critical patent/CN107184963A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明公开了一种医用敷料的制备方法，其包括以下步骤：（1）取EDTA‑2Na、甘油、透明质酸钠、寡聚透明质酸钠、聚天冬氨酸、海藻糖加入水中，搅拌溶解；（2）加入汉生胶、甜菜碱、甲基丙二醇；（3）取卡波姆配制为1%的水分散体，混合均匀；（4）取三乙醇胺、对羟基苯乙酮、1,2 己二醇、1,3－丁二醇、胶原蛋白粉分别在水中溶解均匀，再与步骤（4）得到的混合溶液混合均匀，即得到所述医用敷料。本发明过程简单，制得的医用敷料细胞毒性小，对痤疮具有较好的辅助治疗效果。

Description

一种医用敷料的制备方法
技术领域
本发明涉及皮肤用敷料的技术领域。
背景技术
痤疮，俗称青春痘、粉刺、暗疮等，发病机理较复杂，是目前皮肤科及常见而较难治疗的皮肤疾病，特别易在脸部产生，严重影响外观形象。
发明内容
本发明的目的在于提出一种可用于痤疮辅助治疗、细胞毒性小，安全性高，可同时适用于普通人群或皮肤科病患的医用敷料的制备方法。
本发明的技术方案如下：
一种医用敷料的制备方法，包括以下步骤：
（1）取EDTA-2Na、甘油、透明质酸钠、寡聚透明质酸钠、聚天冬氨酸、海藻糖加入水中，搅拌溶解；
（2）加入汉生胶、甜菜碱、甲基丙二醇与步骤（1）得到的混合溶液搅拌混合均匀；
（3）取卡波姆配制为1%的水分散体，将其与步骤（2）得到的混合溶液再混合均匀；
（4）另取三乙醇胺、对羟基苯乙酮、1,2 己二醇、1,3－丁二醇、胶原蛋白粉分别在水中溶解均匀，与步骤（4）得到的混合溶液再混合均匀，即得到所述医用敷料。
优选的是：所述透明质酸钠为中分子透明质酸钠。
另外优选的是：所述卡波姆为卡波姆941。
另外优选的是：其按质量份计，包括以下组分：EDTA-2Na0.04~0.08份，甘油2.0~6.0份，中分子透明质酸钠0.01~0.04份，寡聚透明质酸钠0.02~0.06份，聚天冬氨酸0.6~1.0份，海藻糖0.2~0.6份，汉生胶0.01~0.05份，甜菜碱0.6~1.0份，甲基丙二醇 2.0~6.0份，卡波姆941的1%水分散体10.0~20.0份，三乙醇胺0.08~0.16份，对羟基苯乙酮0.2~0.8份，1,2己二醇0.2~0.8份,1,3－丁二醇2.0~6.0份，胶原蛋白粉0.08~0.2份。
本发明中胶原蛋白对于皮肤修复有良好的辅助治疗效果；对羟基苯乙酮、1,2己二醇可以防止微生物滋生，在本发明的使量下对皮肤无毒性、刺激、致敏反应，安全性高；甘油、中分子透明质酸钠、寡聚透明质酸钠、聚天冬氨酸、海藻糖、1,３－丁二醇配合使用，即能够起到保湿、润滑作用，又可以促进其它成分功能的发挥；汉生胶、卡波姆可以增加溶液粘稠度，使溶液保持水凝胶状态；三乙醇胺有效调节溶液pH值；EDTA-2Na可能保持溶液稳定，使其不发生变质；在制备过程中不同组分根据相容性及稳定性等特性按不同的顺序及组合进行混溶，特别是卡波姆通过配制为1%的水分散体先进行溶胀，可得到性能稳定均一的医用敷料。
本发明制得的医用敷料细胞毒性小，对痤疮具有较好的辅助治疗效果，同时安全性高，即可用于普通人群，也可用于医院皮肤科的痤疮病患，具有广泛的应用群体，制备方法可控性好，操作简单，可进行大规模生产。
具体实施方式
实施例1
（1）取EDTA-2Na、甘油、中分子透明质酸钠、寡聚透明质酸钠、聚天冬氨酸、海藻糖加入水中，搅拌溶解；
（2）加入汉生胶、甜菜碱、甲基丙二醇与步骤（1）得到的混合溶液搅拌混合均匀；
（3）取卡波姆941配制为1%的水分散体，将其与步骤（2）得到的混合溶液再混合均匀；
（4）另取三乙醇胺、对羟基苯乙酮、1,2 己二醇、1,3－丁二醇、胶原蛋白粉分别在水中溶解均匀，与步骤（4）得到的混合溶液再混合均匀，即得到所述医用敷料；
其中各原料质量份为：EDTA-2Na0.04份，甘油2.0份，中分子透明质酸钠0.01份，寡聚透明质酸钠0.02份，聚天冬氨酸0.6份，海藻糖0.2份，汉生胶0.01份，甜菜碱0.6份，甲基丙二醇 2.0，卡波姆941的1%水分散体10.0份，三乙醇胺0.08份，对羟基苯乙酮0.2份，1,2 己二醇0.2份,1,3－丁二醇2.0份，胶原蛋白粉0.08份。
实施例2
（1）取EDTA-2Na、甘油、中分子透明质酸钠、寡聚透明质酸钠、聚天冬氨酸、海藻糖加入水中，搅拌溶解；
（2）加入汉生胶、甜菜碱、甲基丙二醇与步骤（1）得到的混合溶液搅拌混合均匀；
（3）取卡波姆941配制为1%的水分散体，将其与步骤（2）得到的混合溶液再混合均匀；
（4）另取三乙醇胺、对羟基苯乙酮、1,2 己二醇、1,3－丁二醇、胶原蛋白粉分别在水中溶解均匀，与步骤（4）得到的混合溶液再混合均匀，即得到所述医用敷料；
其中各原料质量份为：EDTA-2Na0.08份，甘油6.0份，中分子透明质酸钠0.04份，寡聚透明质酸钠0.06份，聚天冬氨酸1.0份，海藻糖0.6份，汉生胶0.05份，甜菜碱1.0份，甲基丙二醇6.0份，卡波姆941的1%水分散体20.0份，三乙醇胺0.16份，对羟基苯乙酮0.8份，1,2 己二醇0.8份,1,3－丁二醇6.0份，胶原蛋白粉0.2份。

Claims (4)

1.一种医用敷料的制备方法，其特征在于：包括以下步骤：
（1）取EDTA-2Na、甘油、透明质酸钠、寡聚透明质酸钠、聚天冬氨酸、海藻糖加入水中，搅拌溶解；
（2）加入汉生胶、甜菜碱、甲基丙二醇与步骤（1）得到的混合溶液搅拌混合均匀；
（3）取卡波姆配制为1%的水分散体，将其与步骤（2）得到的混合溶液再混合均匀；
（4）另取三乙醇胺、对羟基苯乙酮、1,2 己二醇、1,3－丁二醇、胶原蛋白粉分别在水中溶解均匀，与步骤（4）得到的混合溶液再混合均匀，即得到所述医用敷料。
2.根据权利要求1所述的医用敷料的制备方法，其特征在于：所述透明质酸钠为中分子透明质酸钠。
3.根据权利要求1所述的医用敷料的制备方法，其特征在于：所述卡波姆为卡波姆941。
4.根据权利要求1所述的医用敷料的制备方法，其特征在于：其按质量份计，其原料为：EDTA-2Na0.04~0.08份，甘油2.0~6.0份，中分子透明质酸钠0.01~0.04份，寡聚透明质酸钠0.02~0.06份，聚天冬氨酸0.6~1.0份，海藻糖0.2~0.6份，汉生胶0.01~0.05份，甜菜碱0.6~1.0份，甲基丙二醇 2.0~6.0份，卡波姆941的1%水分散体10.0~20.0份，三乙醇胺0.08~0.16份，对羟基苯乙酮0.2~0.8份，1,2 己二醇0.2~0.8份,1,3－丁二醇2.0~6.0份，胶原蛋白粉0.08~0.2份。
CN201710501553.9A 2017-06-27 2017-06-27 一种医用敷料的制备方法 Withdrawn CN107184963A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710501553.9A CN107184963A (zh) 2017-06-27 2017-06-27 一种医用敷料的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710501553.9A CN107184963A (zh) 2017-06-27 2017-06-27 一种医用敷料的制备方法

Publications (1)

Publication Number Publication Date
CN107184963A true CN107184963A (zh) 2017-09-22

Family

ID=59880127

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710501553.9A Withdrawn CN107184963A (zh) 2017-06-27 2017-06-27 一种医用敷料的制备方法

Country Status (1)

Country Link
CN (1) CN107184963A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109077947A (zh) * 2018-08-30 2018-12-25 湖北舒邦药业有限公司 一种医用眼科冷敷敷料及其制备方法
CN111467561A (zh) * 2020-05-21 2020-07-31 绽妍生物科技有限公司 一种含有海藻糖可修复皮肤屛障的敷料及其制造工艺

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109077947A (zh) * 2018-08-30 2018-12-25 湖北舒邦药业有限公司 一种医用眼科冷敷敷料及其制备方法
CN111467561A (zh) * 2020-05-21 2020-07-31 绽妍生物科技有限公司 一种含有海藻糖可修复皮肤屛障的敷料及其制造工艺
CN111467561B (zh) * 2020-05-21 2020-12-11 绽妍生物科技有限公司 一种含有海藻糖可修复皮肤屛障的敷料及其制造工艺

Similar Documents

Publication Publication Date Title
CN107376002A (zh) 一种用于治疗皮肤病的医用敷料的制备方法
CN102462640B (zh) 海洋鱼皮胶原蛋白保湿抗衰老化妆品及其制备方法
CN105476950B (zh) 保湿泡沫洁面乳及其制备方法
CN104887561A (zh) 一种医用海洋生物成分的水凝胶护眼贴
CN102988199B (zh) 嫩肤抗敏精华液
CN1682690A (zh) 沐浴液组合物及其制备方法
CN107184963A (zh) 一种医用敷料的制备方法
CN107362108A (zh) 一种金花葵面膜及其制备方法
JP2010095464A (ja) 皮膚外用剤およびその製造方法
CN106265149A (zh) 一种抗皱霜
CN104983630A (zh) 洁白柔肤水及其制备方法
CN107184962A (zh) 一种医用敷料
KR20140048700A (ko) 검버섯 및 잔주름 개선기능을 갖는 생약숙성탕액을 이용한 천연비누 및 그 제조방법
CN104958788A (zh) 一种医用润滑剂及其制备方法
CN107376003A (zh) 一种用于治疗皮肤病的医用敷料
JP2005330285A (ja) 皮膚保湿用化粧料組成物
CN108451818A (zh) 一种榆树皮提取液及其制备方法和应用
CN100464732C (zh) 一种矿物黑泥面膜的生产方法
CN107982111A (zh) 一种含有桧木芬多精爽肤水及其制备方法
KR20160110769A (ko) 겔 마스크팩 조성물
JP6957289B2 (ja) 美白化粧料組成物
KR101178368B1 (ko) 캡사이신 함유 러버 마스크 분말조성물
CN108245476A (zh) 一种美白淡斑面膜及其制备方法
CN107557190A (zh) 一种3d打印手工皂及其制备方法
CN107865784A (zh) 一种基于协同美白作用的纳米级胶束爽肤水

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170922